Diabetes and risk of adverse events with calcium antagonists

被引:27
作者
Pahor, M
Kritchevsky, SB
Zuccala, G
Guralnik, JM
机构
[1] Univ Tennessee, Dept Prevent Med, Memphis, TN 38105 USA
[2] Catholic Univ Rome, Dept Internal Med & Geriatr, Rome, Italy
[3] NIA, Epidemiol Demog & Biometry Program, Bethesda, MD 20892 USA
关键词
D O I
10.2337/diacare.21.1.193
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:193 / 194
页数:2
相关论文
共 11 条
[1]   Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events [J].
Byington, RP ;
Craven, TE ;
Furberg, CD ;
Pahor, M .
LANCET, 1997, 350 (9084) :1075-1076
[2]   NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J].
FURBERG, CD ;
PSATY, BM ;
MEYER, JV .
CIRCULATION, 1995, 92 (05) :1326-1331
[3]   Calcium-channel blockers and risk of cancer [J].
Jick, H ;
Jick, S ;
Derby, LE ;
Vasilakis, C ;
Myers, MW ;
Meier, CR .
LANCET, 1997, 349 (9051) :525-528
[5]  
NEHAL M, 1990, BIOCHEM INT, V22, P243
[6]   Calcium-channel blockade and incidence of cancer in aged populations [J].
Pahor, M ;
Guralnik, JM ;
Ferrucci, L ;
Corti, MC ;
Salive, ME ;
Cerhan, JR ;
Wallace, RB ;
Havlik, RJ .
LANCET, 1996, 348 (9026) :493-497
[7]   Do calcium channel blockers increase the risk of cancer? [J].
Pahor, M ;
Guralnik, JM ;
Salive, ME ;
Corti, MC ;
Carbonin, P ;
Havlik, RJ .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (07) :695-699
[8]   LONG-TERM SURVIVAL AND USE OF ANTIHYPERTENSIVE MEDICATIONS IN OLDER PERSONS [J].
PAHOR, M ;
GURALNIK, JM ;
CORTI, MC ;
FOLEY, DJ ;
CARBONIN, P ;
HAVLIK, RJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (11) :1191-1197
[9]   Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old [J].
Pahor, M ;
Guralnik, JM ;
Furberg, CD ;
Carbonin, P ;
Havlik, RJ .
LANCET, 1996, 347 (9008) :1061-1065
[10]  
TATTI P, 1997, CIRCULATION S1, V96, P764